Debt-to-equity in % of CANNAPHARMARX, INC. from Q3 2015 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
CANNAPHARMARX, INC. quarterly Debt-to-equity history and change rate from Q3 2015 to Q3 2025.
  • CANNAPHARMARX, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was -153 %.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

CANNAPHARMARX, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -153 30 Sep 2025
Q2 2025 -157 30 Jun 2025
Q1 2024 -144 +141 +49.5% 31 Mar 2024
Q4 2023 -139 +176 +56% 31 Dec 2023
Q3 2023 -234 -104 -79.8% 30 Sep 2023
Q2 2023 -256 -117 -84% 30 Jun 2023
Q1 2023 -285 -130 -84% 31 Mar 2023
Q4 2022 -315 -138 -78.5% 31 Dec 2022
Q3 2022 -130 +87.7 +40.2% 30 Sep 2022
Q2 2022 -139 +169 +54.9% 30 Jun 2022
Q1 2022 -155 +381 +71.1% 31 Mar 2022
Q4 2021 -176 +1.6K +90.1% 31 Dec 2021
Q3 2021 -218 -714 -144% 30 Sep 2021
Q2 2021 -308 -523 -243% 30 Jun 2021
Q1 2021 -536 -675 -487% 31 Mar 2021
Q4 2020 -1.77K -1.87K -1982% 31 Dec 2020
Q3 2020 496 +390 +371% 30 Sep 2020
Q2 2020 215 +80.8 +60% 30 Jun 2020
Q1 2020 139 -85.4 -38.1% 31 Mar 2020
Q4 2019 94.2 +515 31 Dec 2019
Q3 2019 105 +225 30 Sep 2019
Q2 2019 135 +235 30 Jun 2019
Q1 2019 224 +324 31 Mar 2019
Q4 2018 -421 -321 -321% 31 Dec 2018
Q3 2018 -119 -19.2 -19.1% 30 Sep 2018
Q2 2018 -101 -0.42 -0.42% 30 Jun 2018
Q1 2018 -100 +0.36 +0.36% 31 Mar 2018
Q4 2017 -100 +0.94 +0.93% 31 Dec 2017
Q3 2017 -100 +1.29 +1.27% 30 Sep 2017
Q2 2017 -100 +13.8 +12.1% 30 Jun 2017
Q1 2017 -100 +110 +52.3% 31 Mar 2017
Q4 2016 -101 +291 +74.3% 31 Dec 2016
Q3 2016 -101 +752 +88.1% 30 Sep 2016
Q2 2016 -114 30 Jun 2016
Q1 2016 -210 31 Mar 2016
Q4 2015 -392 31 Dec 2015
Q3 2015 -853 30 Sep 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.